Abstract:Background: Human cytomegalovirus (HCMV) is the most frequent cause of congenital infections and can lead to adverse pregnancy outcomes (APOs). HCMV encodes multiple microRNAs (miRNAs) that have been reported to be partially related to host immune responses, cell cycle regulation, viral replication, and viral latency, and can be detected in human plasma. However, the relevance for HCMV-encoded miRNAs in maternal plasma as an indicator for APOs has never been evaluated. Methods: Expression profiles of 22 HCMV-encoded miRNAs were first measured in plasma samples from 20 pregnant women with APOs and 28 normal controls using quantitative reverse-transcription polymerase chain reaction. Next, markedly changed miRNAs were validated in another independent validation set consisting of 20 pregnant women with APOs and 27 control subjects. Markedly changed miRNAs were further assessed in the placenta tissues. HCMV DNA in peripheral blood leukocytes (PBLs) and anti-HCMV immunoglobulin M (IgM) and anti-HCMV immunoglobulin G (IgG) in plasma were also examined in both training and validation sets. Diagnostic value and risk factors were compared between APO cohorts and normal controls. Results: Analysis of the training and validation data sets revealed that plasma concentrations of hcmv-miR-UL148D, hcmv-miR-US25-1-5p and hcmv-miR-US5-1 were significantly increased in pregnant women with APOs compared with normal controls. Hcmv-miR-US25-1-5p presented the largest area under the receiver-operating characteristic (ROC) curve (AUC) (0.735; 95% CI, 0.635-0.836), with a sensitivity of 68% and specificity of 71%. Furthermore, plasma levels of hcmv-miR-US25-1-5p and hcmv-miRUS5-1 correlated positively with APOs (P=0.029 and 0.035, respectively). Hcmv-miR-US25-1-5p in the placenta tissues were dramatically increased in APOs, and correlated with plasma hcmv-miR-US25-1-5p. Nevertheless, neither the concentration of HCMV DNA in PBLs nor the positivity rates of anti-HCMV IgM and anti-HCMV IgG in plasma showed a statistically significant correlation with APOs. Conclusions: We identified a unique signature of HCMV-encoded miRNAs in pregnant women with APOs that may be useful as a potential noninvasive biomarker for predicting and monitoring APOs during HCMV infection.

Assessment of HCMV-encoded Micrornas in Plasma As Potential Biomarkers in Pregnant Women with Adverse Pregnancy Outcomes

Integrative Analysis of Circulating Micrornas and the Placental Transcriptome in Recurrent Pregnancy Loss

A comprehensive survey of maternal plasma miRNAs expression profiles using high-throughput sequencing.

Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects.

Cell-free DNA Methylation and Transcriptomic Signature Prediction of Pregnancies with Adverse Outcomes

Differential Expression of Circulating Mirnas in Maternal Plasma in Pregnancies with Fetal Macrosomia

Study of Human Cytomegalovirus Replication in Body Fluids, Placental Infection, and Miscarriage During the First Trimester of Pregnancy

INVESTIGATION OF MICRORNA LEVELS IN BLOOD PLASMA IN PREGNANT WOMEN WITH GESTATIONAL ARTERIAL HYPERTENSION, PREECLAMPSIA, AND FETAL GROWTH RETARDATION SYNDROME

COVID-19 Vaccination in Pregnancy: Pilot Study of Plasma MicroRNAs Associated with Inflammatory Cytokines after COVID-19 mRNA Vaccination

Unique Microrna Expression Profiles in Plasmic Exosomes from Intrahepatic Cholestasis of Pregnancy

Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus.

Variations of MicroRNAs in Human Placentas and Plasma from Preeclamptic Pregnancy

The correlation between active infection of HCMV and the serum level of PAPP-A in women with threatened abortion in early trimester of pregnancy.

Expression Profile of Maternal Circulating Micrornas As Non-Invasive Biomarkers for Prenatal Diagnosis of Congenital Heart Defects.

Discrimination of Primary and Chronic CMV Infection based on Humoral Immune Profiles in Pregnancy

MicroRNA–mRNA Networks in Pregnancy Complications: A Comprehensive Downstream Analysis of Potential Biomarkers

Detection Of Placental Mirnas In Maternal Plasma

Circulating Micrornas As Biomarkers for Diagnosis and Prediction of Preeclampsia: A Systematic Review and Meta-Analysis

Placenta-Specific Circulating Mircornas and Their Variants As Potential Biomarkers for Preeclampsia

Maternal Plasma Mirnas Expression in Preeclamptic Pregnancies

Human cytomegalovirus-encoded microRNAs expression profile in plasma of patients with aortic dissection